Cover Image

Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P. Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Annals of Clinical and Translational Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MuSK‐Myasthenia Gravis and Cancer
by: Shigeaki Suzuki, et al.
Published: (2024)

Pathogenic Role of Age‐Associated B Cells in Autoimmune Disorders and Myasthenia Gravis
by: Hiroyuki Akamine, et al.
Published: (2025)

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry
by: Akiyuki Uzawa, et al.
Published: (2025)

Response to: Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis
by: Akiyuki Uzawa, et al.
Published: (2025)

Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study
by: James F. Howard, et al.
Published: (2024)

Development of myasthenia gravis: 4 years after durvalumab‐induced myositis
by: Yasunobu Nosaki, et al.
Published: (2024)

Ocular myasthenia gravis and thymoma
by: Victor Alegre-Ituarte
Published: (2022)

Immune repertoire profiling in myasthenia gravis
by: Ting He, et al.
Published: (2024)

What is the prevalence of myasthenia gravis in the United States?
by: Tripdatabase
Published: (2026)

Investment centre manager's multiperiod fairness perceptions and intertemporal dependency
by: Hiroyuki Selmes‐Suzuki
Published: (2024)

The impact of myasthenia gravis severity on work and daily activities
by: Jacqueline Pesa, et al.
Published: (2024)

Intensive care due to myasthenia gravis: Risk factors and prognosis
by: Chris Myllynen, et al.
Published: (2024)

Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis
by: Zhe Ruan, et al.
Published: (2024)

Breaking the Barriers of Database-Agnostic Transactions
by: Suzuki, Toshihiro, et al.
Published: (2026)

(Table 1) Relative abundances of biphytanediols and biphytanes in IODP Site 315-C0001
by: Saito, Hiroyuki, et al.
Published: (2010)

Is oral frailty a cause or a consequence?
by: Ryota Sakurai, et al.
Published: (2024)

Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation
by: Benjamin Beland, et al.
Published: (2024)

Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
by: Nils Erik Gilhus, et al.
Published: (2024)

In vitro modulation of T cells in myasthenia gravis by low‐dose IL‐2
by: Merve Çebi, et al.
Published: (2024)

A case of anti‐p200 pemphigoid associated with myasthenia gravis
by: Sae Ogawa, et al.
Published: (2025)

Pulmonary Mycobacterium shinjukuense infection with cavitary lesion
by: Yuriko Sueda, et al.
Published: (2024)

Recurrent respiratory failure with myasthenia gravis‐like immune‐mediated necrotizing myopathy
by: Nattanicha Chaisrimaneepan, et al.
Published: (2024)

Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis
by: Andreas Meisel, et al.
Published: (2024)

How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?
by: Kelly G. Gwathmey, et al.
Published: (2024)

Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
by: David Reyes‐Leiva, et al.
Published: (2024)

Simultaneous Presentation of Thermal and Mechanical Stimulation Using High-Intensity Airborne Ultrasound
by: Iwabuchi, Sota, et al.
Published: (2024)

Extraocular muscle volume on time‐of‐flight magnetic resonance angiography in patients with myasthenia gravis
by: Pei Chen, et al.
Published: (2024)

Epidemiology of seropositive myasthenia gravis in Sardinia: A population‐based study in the district of Sassari
by: Elia Sechi, et al.
Published: (2024)

Immune checkpoint inhibitor‐induced myasthenia gravis, myocarditis, and myositis: A case report
by: Arjun Basnet, et al.
Published: (2024)

Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China
by: Sushan Luo, et al.
Published: (2024)

(Table T3) Diploptene, hop-21-ene, hop-17/21)-ene and neohop-13(18)-ene concentrations of ODP Site 190-1178
by: Suzuki, Noriyuki, et al.
Published: (2004)

n-Alkane, fatty acid and hopanoic acid concentrations of ODP Site 190-1178 samples
by: Suzuki, Noriyuki, et al.
Published: (2004)

(Table T1) Total n-alkane, H/L AL and hopane concentrations and n-alkane CPI of ODP Site 190-1178
by: Suzuki, Noriyuki, et al.
Published: (2004)

(Table T2) Total fatty acid, H/L FA and total hopanoic acid concentrations of ODP Site 190-1178
by: Suzuki, Noriyuki, et al.
Published: (2004)

Passive Touch Experience with Virtual Doctor Fish Using Ultrasound Haptics
by: Yo, Manato, et al.
Published: (2024)

Relapse and Neurological Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Secondary Analysis of a Japanese Nationwide Epidemiologic Survey
by: Masashi Nakamura, et al.
Published: (2026)

Efgartigimod in generalized myasthenia gravis: A real‐life experience at a national reference center
by: Rita Frangiamore, et al.
Published: (2024)

Patient and care partner perspectives and preferences related to myasthenia gravis treatment: A qualitative study
by: Margaret Yung, et al.
Published: (2024)

A boy with transient growth retardation and weight loss due to stimulants, recovering without drug withdrawal
by: Yuriko Katsushima, et al.
Published: (2026)

Endovascular Repair of an Ilio‐Iliac Arteriovenous Fistula Presenting as Acute Lower Limb Edema
by: Yudai Hagihara, et al.
Published: (2026)